argenx SE (STU:1AEA) Stock News, Headlines & Updates
argenx SE Stock News from GuruFocus
- 1
Jun 17, 2024
argenx to unveil its 'Vision 2030: Taking Breakthrough Science to 50,000 Patients' during its Upcoming R&D Day on July 16, 2024
Marketwired • 12:00am
Jun 04, 2024
argenx to Present at Goldman Sachs 45th Annual Global Healthcare Conference
Marketwired • 12:00am
May 09, 2024
argenx Reports First Quarter 2024 Financial Results and Provides Business Update
Marketwired • 12:00am
May 07, 2024
argenx announces results of Annual General Meeting of Shareholders
Marketwired • 5:00pm
argenx to Present at BofA Securities 2024 Health Care Conference
Marketwired • 12:00am
May 02, 2024
argenx to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024
Marketwired • 12:00am
Apr 16, 2024
argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease
Marketwired • 12:00am
Mar 27, 2024
argenx Advances Clinical Development of Efgartigimod in Primary Sjogren's Disease
Marketwired • 1:00am
Mar 26, 2024
argenx Announces Annual General Meeting of Shareholders on May 7, 2024
Marketwired • 3:00pm
argenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thrombocytopenia
Marketwired • 1:00am
Mar 25, 2024
argenx SE at Barclays Global Healthcare Conference Transcript
GuruFocus Research • 5:56pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news